Reactions of the fac-[Re(CO)3] and [ReO] moieties with substituted benzothiazoles

The reaction of 2-(2-aminophenyl)benzothiazole (Habt) with [Re(CO)₅Br] led to the isolation of the rhenium(I) complex fac-[Re(Habt)(CO)₃Br] (1). With trans-[ReOCl₃(PPh₃)₂], the ligand Habt decomposed to form the oxofree rhenium(V) complex [Re(itp)₂Cl(PPh₃)] (2) (itp = 2-amidophenylthiolate). From the reaction of trans-[ReOBr₃(PPh₃)₂] with 2-(2-hydroxyphenyl)benzothiazole (Hhpd) the complex [Re^VOBr₂(hpd)(PPh₃)] (3) was obtained. Complexes 1-3 are stable and lipophilic. ¹H NMR and infrared assignments, as well as the X-ray crystal structures, of the complexes are reported.     

Synthesis and characterization of new imidorhenium(V) and imidorhenium(VI) complexes of pyridyltriazines and pyrazinyltriazine with halide coligands including rare iodide

The blue colored imido complexes [Re(NC₆H₄Cl)X₃(L)] have been synthesized by three methods: (i) reaction of [Re^VOX₃(L)] with p-ClC₆H₄NH₂, (ii) reaction of [Re^III(OPPh₃)X₃(L)] with p-ClC₆H₄NH₂ and (iii) reaction of [Re^VOX₃(PPh₃)₂] with L followed by the addition of p-ClC₆H₄NH₂ in boiling toluene. Here, X = Cl, Br, I and L are 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine (L²) and its dimethyl (L¹) and pyrazinyl (L³) analogues. The [Re(NC₆H₄Cl)Cl₃(L¹)] (1a), [Re(NC₆H₄Cl)Cl₃(L²)] (1b), [Re(NC₆H₄Cl)Br₃(L²)] (1c), [Re(NC₆H₄Cl)I₃(L²)] (1d), [Re(NC₆H₄Cl)Cl₃(L³)] (1e), [Re(NC₆H₄Cl)Br₃(L³)] (1f), [Re(NC₆H₄Cl)I₃(L³)] (1g), complexes have been characterized electrochemically and spectroscopically. The X-ray structures of [Re(NC₆H₄Cl)Cl₃(L²)] and [Re(NC₆H₄Cl)I₃(L³)] reveal that the ReCl₃ fragment is meridionally disposed and that the L ligand is N,N-coordinated such that the pyridine/pyrazine nitrogen lies trans to the imide nitrogen. The feasibility of generating the rhenium(VI) congener of the imidorhenium(V) complex is also examined with the help of six-line EPR spectra at room temperature.     

Synthesis and structural characterization of zwitterionic oxorhenium(V) complexes with 2-hydroxypyridine

[ReOX₃(PPh₃)₂] complexes (X = Cl and Br) react with equivalent amounts of 2-hydroxypyridine (Hhp) under formation of the mono-substituted, zwitterionic complexes mer-[ReOCl₃(Hhp)(PPh₃)] (1) and mer-[ReOBr₃(Hhp)(PPh₃)] (2). Crystal structure determinations of 1 · CH₂Cl₂ and 2 revealed the Cl and Br ligands adopt a mer arrangement. The Hhp ligands coordinate neutral and monodentate via their exocyclic oxygen atoms in axial positions, trans to the oxo groups. The distorted octahedral coordination sphere of the rhenium(V) complexes is completed by the phosphorus atom of the remaining PPh₃ ligand.     

Linear and bent oxo-bridged dinuclear rhenium(V) complexes with terminal and bridging pyrazole ligands

The [ReOX₃(AsPh₃)(OAsPh₃)] (X = Cl or Br) complexes react with two equivalents of 3,5-dimetylopyrazole (3,5-Me₂pzH) in acetone at room temperature to give [{Re(O)X₂(3,5- Me₂pzH)₂}₂(μ-O)] (1 and 2). In the case of [ReOBr₃(AsPh₃)(OAsPh₃)], a small quantity of the dinuclear rhenium complex [{Re(O)Br(3,5-Me₂pzH)}₂(μ-O)(μ-3,5-Me₂pz)₂] (3) has been isolated next to the main product 2. Treatment of [ReOX₃(PPh₃)₂] compounds with two equivalents of 3,5-Me₂pzH in acetone at room temperature leads to the isolation of symmetrically substituted dinuclear rhenium complexes [{Re(O)X(PPh₃)}₂(μ-O)(μ-3,5-Me₂pz)₂] (4 and 5). Refluxing of [ReO(OEt)X₂(PPh₃)₂] complexes with 3,5-Me₂pzH in ethanol affords unsymmetrically substituted dinuclear rhenium [{Re(O)X(PPh₃)}(μ-O)(μ-3,5-Me₂pz)₂{Re(O)X(3,5- Me₂pzH)}] complexes (6 and 7). The complexes obtained in these reactions have been characterised by IR, UV-Vis, ¹H and ³¹P NMR. The crystal and molecular structures have been determined for 1, 2, 3, 4, 6 and 7 complexes.     

Studies of rheniumtricarbonyl complexes of tripodal pyridyl-based ligands

The reaction of N-benzoyl and N-acetyl tris(pyridin-2-yl)methylamine 1b and 1c (LH = tpmbaH and tpmaaH) with [Re(CO)₅Br] has been investigated and shown to proceed via the initial formation of a cationic rheniumtricarbonyl complex [(LH)Re(CO)₃]Br in which coordination of the ligand occurs via the three pyridine rings. For tpmbaH 1b, but not tpmaaH 1c, this initial complex 2b readily undergoes the loss of HBr to give a neutral octahedral complex 4b [(L)Re(CO)₃] where coordination occurs via two of the pyridine rings and the deprotonated amide nitrogen. The ¹H NMR spectrum of the latter complex 4b is very unusual in that at room temperature the signals for the 3-H protons on the coordinated pyridine rings are not visible due to extreme broadening of these resonances. Comparison with the analogous complex 7 from N-benzoyl bis(pyridin-2-yl)methylamine 6b (bpmbaH) confirms that this is due to rotation of the uncoordinated pyridine ring. The structure of the cationic complex 3d [(LH)Re(CO)₃]Br formed from N-benzyl tris(pyridin-2-yl)methylamine 1d (bz-tpmaH) is also discussed. The crystal structures of complexes [(tpmba)Re(CO)₃] 4b, [(bz-tpmaH)Re(CO)₃]Br 3d and [(bpmba)Re(CO)₃] 7 have been determined. In all complexes the coordination geometry around Re is distorted octahedral with a fac-{Re(CO)₃}⁺ core.     

Complexes with the fac-{M(CO)3} (M = Tc, Re) moiety and long alkyl chain ligands as Lipiodol surrogates

Accumulation of radiopharmaceuticals in the liver is frequently observed and represents in general a limiting factor when developing novel labeled compounds for any purpose in nuclear medicine. Aiming at the treatment of liver cancer with radiopharmaceuticals, such accumulation is desired but the compounds have to remain in the liver over an extended time period rather than being washed out or redistributed over time in the whole body. Lipiodol is known to remain in the liver and we present here a study for the preparation of ¹⁸⁶Re and ^99mTc labeled Lipiodol surrogates expected to behave similarly. We have synthesized two bidentate and two tridentate ligands conjugated to a pendant C18 chain as well as their corresponding fac-[Re(CO)₃]⁺ and fac-[Tc(CO)₃]⁺ complexes. Three of the rhenium complexes have been structurally characterized. Labelling with [¹⁸⁶Re(OH₂)₃(CO)₃]⁺ and [^99mTc(OH₂)₃(CO)₃]⁺, respectively, gave yields in the range of 90%. The complexes could be extracted into Lipiodol due to their high lipophilicity and close structural relationship with the major components of Lipiodol. The complexes are stable in water and in Lipiodol for more than 24 h. These Lipiodol surrogates present new low-valent technetium and rhenium complexes for applications in liver cancer imaging and therapy.     

Synthesis, characterization and X-ray crystal structure of [Re(L4)(CO)3]Br · 2CH3OH (L4 = N,N-bis[(2-diphenylphosphino)ethyl]methoxyethylamine): A model compound for novel cationic Tc(I)-tricarbonyl radiotracers useful for heart imaging

This report describes synthesis and evaluation of cationic complexes, [^99mTc(CO)₃(L)]⁺ (L = N-methoxyethyl-N,N-bis[2-(bis(3-ethoxypropyl)phosphino)ethyl]amine (L1), N-[(15-crown-5)-2-yl]-N,N-bis[2-(bis(3-ethoxypropyl)phosphino)ethyl]amine (L2) and N-[(18-crown-6)-2-yl]-N,N-bis[2-(bis(3-ethoxypropyl)phosphino)ethyl]amine (L3)) as potential radiotracers for heart imaging. Preliminary results from biodistribution studies in female adult BALB-c mice indicated that the cationic ^99mTc(I)-tricarbonyl complex, [^99mTc(CO)₃(L2)]⁺, has a significant localization in the heart at 60 min post-injection. To understand the coordination chemistry of these bisphosphine ligands with the ^99mTc(I)-tricarbonyl core, we prepared [Re(CO)₃(L4)]Br (L4: N,N-bis[(2-diphenylphosphino)ethyl]methoxyethylamine) as a model compound. [Re(CO)₃(L4)]Br has been characterized by elemental analysis, IR, ESI-MS, NMR (¹H, ¹³C, ¹H-¹H COSY, and ¹H-¹³C HMQC) methods, and X-ray crystallography. In solid state, [Re(CO)₃(L4)]⁺ has a distorted octahedron coordination geometry with PNP occupying one facial plane. The chelator backbone adopts a “chair” conformation with phosphine-P atoms at equatorial positions and the amine-N at the apical site. In solution, [Re(CO)₃(L4)]⁺ is able to maintain its cationic nature with no dissociation of carbonyl ligands or any of the three PNP donors.     

Benzimidazole derivatives as NSO ligands for the fac-[M(CO)3] (M = Re, Tc)

Two rhenium(I) tricarbonyl complexes with the tridentate monoanionic NSO ligands, 4-(benzimidazol-2-yl)-3-thiabutanoic acid (complex 3) and [1-(11-carboxyundecanyl)-4-(benzimidazol-2-yl)]-3-thiabutanoic acid (complex 4) were synthesized and characterized by spectroscopic methods and elemental analysis. X-ray crystallographic analysis of complex 3 revealed a distorted octahedral geometry around rhenium defined by the three facially bound CO groups and the NSO donor atom set of the tridentate ligand. The analogous technetium-99m complexes (complexes 5 and 6) were also prepared quantitatively by reaction of the NSO ligands with the fac-[^99mTc(H₂O)₃(CO)₃]⁺ synthon and their identity was established by chromatographic comparison to their rhenium congeners. Biodistribution in mice of complex 6 bearing the fatty acid chain showed significant heart uptake (6.26 ± 0.79% ID/g p.i.) at 1 min accompanied, however, with a heart:blood ratio below 1.     

Ethylenediamine- and propylenediaminediacetic acid derivatives as ligands for the “fac-[M(CO)3]” core (M = Re, Tc)

The reaction of Re(CO)₅Cl with o- or p-N-(nitrophenyl)ethylenediaminediacetic acid (H₂L¹, H₂L²) and o- or p-N-(nitrophenyl)propylenediaminediacetic acid (H₂L³, H₂L⁴) in methanol leads to the formation of stable anionic [Et₃NH][Re(CO)₃(L)] · H₂O complexes 1-4. These compounds have been characterized by means of IR, mass spectrometry, elemental analysis, NMR and conductimetry, as well as X-ray crystallography for 2 and 3. The [Re(CO)₃]⁺ moiety is coordinated via the nitrogen of the iminodiacetic acid unit and two oxygens of monodentate carboxylate groups. In each case, the nitro group of the aromatic ring remains uncoordinated. The analogous technetium-99m complexes 1′ and 3′ were also prepared quantitatively by the reaction of H₂L¹ and H₂L³, respectively, with the fac-[^99mTc(CO)₃(H₂O)₃]⁺ precursor in ethanol. The corresponding Re and ^99mTc compounds were shown to possess the same structure by means of HPLC studies. The high affinity of these ligands for the Tc(I) or Re(I) core, coupled with the easiness of their derivatization (by reduction of the nitro group in amino group), implies that the utilization of this ligand system to develop target-specific radiopharmaceuticals for diagnosis and therapy is promising.     

6-Halogenopyridin-2-olato complexes with the diruthenium(2+) core: Equilibria between head-to-head and head-to-tail structures

The dinuclear bis(6-X-pyridin-2-olato) ruthenium complexes [Ru₂(μ-XpyO)₂(CO)₄(PPh₃)₂] (X = Cl (4B) and Br (5B)), [Ru₂(μ-XpyO)₂(CO)₄(CH₃CN)₂] (X = Cl (6B), Br (7B) and F (8B)) and [Ru₂(μ-ClpyO)₂(CO)₄(PhCN)₂] (9B) were prepared from the corresponding tetranuclear coordination dimers [Ru₂(μ-XpyO)₂(CO)₄]₂ (1: X = Cl; 2: X = Br) and [Ru₂(μ-FpyO)₂(CO)₆]₂ (3) by treatment with an excess of triphenylphosphane, acetonitrile and benzonitrile, respectively. In the solid state, complexes 4B-9B all have a head-to-tail arrangement of the two pyridonate ligands, as evidenced by X-ray crystal structure analyses of 4B, 6B and 9B, in contrast to the head-to-head arrangement in the precursors 1-3. A temperature- and solvent-dependent equilibrium between the yellow head-to-tail complexes and the red head-to-head complexes 4A-7A and 9A, bearing an axial ligand only at the O,O-substituted ruthenium atom, exists in solution and was studied by NMR spectroscopy. Full ¹H and ¹³C NMR assignments were made in each case. Treatment of 1 and 2 with the N-heterocyclic carbene (NHC) 1-butyl-3-methylimidazolin-2-ylidene provided the complexes [Ru₂(μ-XpyO)₂(CO)₄(NHC)], X = Cl (11A) or Br (12A). An XRD analysis revealed the head-to-head arrangement of the pyridonate ligands and axial coordination of the carbene ligand at the O,O-substituted ruthenium atom. The conversion of 11A and 12A into the corresponding head-to-tail complexes was not possible.     

Rhenium tricarbonyl complexes of 1-benzyl-4-(5-bipyridyl)-1H-1,2,3-triazoles

Copper(I) catalyzed [3+2] cycloaddition reactions between 5-ethynylbipyridine and benzyl, p-methylbenzyl, or m-bromobenzyl azides yields the corresponding 1-benzyl-4-(5-bipyridyl)-1H-1,2,3-triazoles 1-3. Reaction between 1-3 and [NEt₄]₂[Re(CO)₃Br₃] yields the [1-benzyl-4-(5-bipyridyl)-1H-1,2,3-triazole]Re(CO)₃Br complexes 4-6. The Re(CO)₃Br complexes of 5- and 6-ethynylbipyridine complexes (7-8) are prepared in a similar fashion. Cycloaddition reactions between 7 and benzyl azide yields mixtures of 4 and unreacted starting material.     

Preparation of trihydridostannyl complexes of rhenium stabilised by isocyanide ligands

Mixed-ligand complexes [ReBr(CO)₂(CNR)_nL_3−n] (1-4) [R = 4-CH₃OC₆H₄, 4-CH₃C₆H₄, C(CH₃)₃; L = P(OEt)₃, PPh(OEt)₂; n = 1, 2] were prepared by allowing carbonyl compounds [ReBr(CO)₄L] and [ReBr(CO)₃L₂] to react with an excess of isocyanide. Treatment of these bromocomplexes [ReBr(CO)₂(CNR)_nL_3−n] with SnCl₂ · 2H₂O yielded the trichlorostannyl derivatives [Re(SnCl₃)(CO)₂(CNR)_nL_3−n] (5-8). Trihydridestannyl complexes [Re(SnH₃)(CO)₂(CNR)_nL_3−n] (9-12) were prepared by allowing trichlorostannyl compounds 5-8 to react with NaBH₄ in ethanol. The trimethylstannyl derivative [Re(SnMe₃)(CO)₂(CNC₆H₄-4-CH₃){PPh(OEt)₂}₂] (13b) was also prepared by treating [Re(SnCl₃)(CO)₂(CNC₆H₄-4-CH₃){PPh(OEt)₂}₂] with an excess of MgBrMe in diethylether. Reaction of the tin trihydride complexes [Re(SnH₃)(CO)₂(CNR)_nL_3−n] (9-12) with CO₂ (1 atm) led to dinuclear OH-bridging bis(formate) derivatives [Re{Sn(OC(H)O)₂(μ-OH)}(CO)₂(CNR)_nL_3−n]₂ (14, 15). The complexes were characterised spectroscopically (IR, ¹H, ³¹P, ¹³C, ¹¹⁹Sn NMR) and by X-ray crystal structure determination of [Re(SnH₃)(CO)₂{CNC(CH₃)₃}{PPh(OEt)₂}₂] (10b).     

Synthesis and characterisation of palladium(II) and platinum(II) compounds containing pyrazole-derived ligands: crystal structure of [PdCl2(HL)] (HL = 3-phenyl-5-(2-pyridyl)pyrazole)

Reaction of the ligands 3-phenyl-5-(2-pyridyl)pyrazole (HL¹), 3,5-bis(2-pyridyl)pyrazole (HL²), 3-methyl-5-(2-pyridyl)pyrazole (HL³) and 3-methyl-5-phenylpyrazole (HL⁴) with [MCl₂(CH₃CN)₂] (M = Pd(II), Pt(II)) or [PdCl₂(cod)] gives complexes with stoichiometry [PdCl₂(HL)₂] (HL = HL¹, HL², HL³), [Pt(L)₂] (L = L¹, L², L³) and [MCl₂(HL⁴)₂] (M = Pd(II), Pt(II)). The new complexes were characterised by elemental analyses, conductivity measurements, infrared and ¹H NMR spectroscopies. The crystal and molecular structure of [PdCl₂(HL¹)] was resolved by X-ray diffraction, and consists of monomeric cis-[PdCl₂(HL¹)] molecules. The palladium centre has a typical square planar geometry, with a slight tetrahedral distortion. The tetra-coordinated metal atom is bonded to one pyridine nitrogen, one pyrazolic nitrogen and two chloro ligands in a cis disposition. The ligand HL¹ is not completely planar.     

Syntheses and molecular structures of 6-halogeno-pyridin-2-olate complexes with the diruthenium(2+) core

The complexes [Ru₂(CO)₅(μ-FpyO)₂]₂ (1), [Ru₂(CO)₄(μ-ClpyO)₂]₂ (2), and [Ru₂(CO)₄(μ-BrpyO)₂]₂ (3) were prepared from Ru₃(CO)₁₂ and 6-fluoro-2-hydroxypyridine (FpyOH), 6-chloro-2-hydroxypyridine (ClpyOH) and 6-bromo-2-hydroxypyridine (BrpyOH), respectively, in hot toluene. Compounds 1-3 are coordination dimers with a cyclo-RuORuO motif. By carrying out the reaction in hot methanol, the dinuclear complexes [Ru₂(CO)₄(μ-ClpyO)₂(CH₃OH)] (4) and [Ru₂(CO)₄(μ-BrpyO)₂(CH₃OH)] (5), respectively, were obtained. Treatment of 2 and 3 with triphenylphosphane provided the complexes [Ru₂(CO)₄(μ-ClpyO)₂(PPh₃)] (6) and [Ru₂(CO)₄(μ-BrpyO)₂(PPh₃)] (7), respectively. The solid-state structures of complexes 1, 2, 4, 6, and 7 were determined by single crystal X-ray diffraction. In all cases, a head-head coordination of the two 6-halopyridinolate ligands at the core was found. In all chlorine- or bromine-containing complexes, the axial coordination site at the ruthenium atom neighbored by two Cl or Br atoms remains unoccupied due to steric shielding by the halogen atom. In the fluoropyridinolate complex 1, the same coordination site is occupied by a carbonyl ligand.     

First example of well-characterized Re and Tc tricarbonyl complexes of ciprofloxacin and norfloxacin in the development of infection-specific imaging agents

Aiming at the development of ^99mTc-based infection-specific imaging agents, the synthesis and characterization of rhenium and technetium-99m tricarbonyl complexes with derivatized ciprofloxacin and norfloxacin is hereby reported. The ligands were prepared by coupling the tridentate chelator picolylamino-N,N-diacetic acid (PADA) with the piperazinyl (NH) nitrogen of ciprofloxacin or norfloxacin, through the employment of the PADA anhydride. The corresponding rhenium complexes were synthesized using the fac-[NEt₄]₂[ReBr₃(CO)₃] precursor and were fully characterized by elemental analysis and NMR spectroscopy. X-ray crystallography of the ciprofloxacin complex showed that the geometry about rhenium is distorted octahedral defined by the NNO donor atom set of the tridentate chelator and the three carbonyl groups. The analogous technetium-99m complexes were prepared quantitatively through the use of the fac-[^99mTc(H₂O)₃(CO)₃]⁺ precursor and their structure was established by comparative HPLC studies using the well-characterized rhenium complexes as reference. Preliminary studies with the technetium-99m complexes showed high bacterial uptake in vitro.     

Rhenium(III) and technetium(III) complexes with 2-mercapto-1,3-azole ligands and X-ray crystal structures

Reactions of labile [MCl₃(PPh₃)₂(NCMe)] (M = Tc, Re) precursors with 1H-benzoimidazole-2-thiol (H₂L¹), 5-methyl-1H-benzoimidazole-2-thiol (H₂L²) and 1H-imidazole-2-thiol (H₂L³), in the presence of PPh₃ and [AsPh₄]Cl gave a new series of trigonal bipyramidal M(III) complexes [AsPh₄]{[M(PPh₃)Cl(H₂L^1-3)₃]Cl₃} (M = Re, 1-3; M = Tc, 4-6). The molecular structures of 1 and 3 were determined by X-ray diffraction. When the reactions were carried out with benzothiazole-2-thiol (HL⁴) and benzoxazole-2-thiol (HL⁵), neutral paramagnetic monosubstituted M(III) complexes [M(PPh₃)₂Cl₂(L^4,5)] (M = Re, 8, 9; M = Tc, 10, 11) were obtained. In these compounds, the central metal ions adopt an octahedral coordination geometry as authenticated by single crystal X-ray diffraction analysis of 8 and 11. Rhenium and technetium complexes 1, 4 and rhenium chelate compounds 8, 9 have been also synthesized by reduction of [MO₄]⁻ with PPh₃ and HCl in the presence of the appropriate ligand. All the complexes were characterized by elemental analyses, FTIR and NMR spectroscopy.     

Syntheses and structures of vinyl and aryl derivatives of carbonyl halide iron complexes

cis,trans-Fe(CO)₂(PMe₃)₂(p-Y-C₆H₄)X [X=Br, Y=H (4a), MeO (4b), Cl (4c), F (4d), Me (4e); X=I, Y=H (5); X=Cl, Y=H (6)] and cis,trans-Fe(CO)₂(PMe₃)₂(σ-CHCH₂)X [X=Br (7); X=I (8); X=Cl (9)] are prepared by reacting dihalide complexes cis,trans,cis- Fe(CO)₂(PMe₃)₂X₂ [X=Br (1), X=I (2), X=Cl (3)] with Grignard reagents p-Y-C₆H₄-MgBr (Y=H, OMe, Cl, F, Me) or CH₂CH-MgBr and with lithium reagents PhLi, CH₂CH-Li. With both reagents, the reaction proceeds following two parallel pathways: one is the metallation reaction which yields alkyl derivatives, the other affords 17 electron complexes [Fe(CO)₂(PMe₃)₂X] via monoelectron reductive elimination. The influence of the halides and organometallic reagents on the yield of the metallation reaction is discussed. The solution structure of the complexes is assigned on the basis of IR and ¹H, ¹³C, ¹⁹F, ³¹P NMR spectra. The solid state structure of complexes 4a, 5 and 6 is determined by single crystal X-ray diffractometric methods.     

Synthesis and properties of new trinuclear Mo(II) complexes containing imidazole and benzimidazole ferrocene units

The reaction of FcCOCl (Fc = (C₅H₅)Fe(C₅H₄)) with benzimidazole or imidazole in 1:1 ratio gives the ferrocenyl derivatives FcCO(benzim) (L1) or FcCO(im) (L2), respectively. Two molecules of L1 or L2 can replace two nitrile ligands in [Mo(η³-C₃H₅)(CO)₂(CH₃CN)₂Br] or [Mo(η³- C₅H₅O)(CO)₂(CH₃CN)₂Br] leading to the new trinuclear complexes [Mo(η³-C₃H₅)(CO)₂(L)₂Br] (C1 for L = L1; C3 for L = L2) and [Mo(η³-C₅H₅O)(CO)₂(L)₂Br] (C2 for L = L1; C4 for L = L2) with L1 and L2 acting as N-monodentade ligands. L1, L2 and C2 were characterized by X-ray diffraction studies. [Mo(η³-C₅H₅O)(CO)₂(L1)₂Br] was shown to be a trinuclear species, with the two L1 molecules occupying one equatorial and one axial position in the coordination sphere of Mo(II). Cyclic voltammetric studies were performed for the two ligands L1 and L2, as well as for their molybdenum complexes, and kinetic and thermodynamic data for the corresponding redox processes obtained. In agreement with the nature of the frontier orbitals obtained from DFT calculations, L1 and L2 exhibit one oxidation process at the Fe(II) center, while C1, C3, and C4 display another oxidation wave at lower potentials, associated with the oxidation of Mo(II).     

New rhenium complexes with ciprofloxacin as useful models for understanding the properties of [99mTc]-ciprofloxacin radiopharmaceutical

Rhenium complexes with the antibiotic ciprofloxacin have been prepared to be studied as models of technetium radiopharmaceuticals. With this aim, the new rhenium complexes 1 {[ReO(Cpf)₂]Cl}, 2 {[ReO(CpfH)₂]Cl₃} and 3 {fac-[Re(CO)₃(H₂O)(Cpf)]} with ciprofloxacin (CpfH = ciprofloxacin; Cpf = conjugated base of ciprofloxacin) have been synthesised and characterised by elemental analyses, IR, NMR (¹H, ¹⁹F and ¹³C CP-MAS) spectroscopy, as well as MS measurements. All spectroscopic data are consistent with the coordination of ciprofloxacin in all these complexes through the carbonyl and the carboxylate oxygen atoms with the formation of a six member chelate ring.The study of a Tc-ciprofloxacin solution by ESI–MS reveals the presence of [TcO(Cpf)₂]⁺ cations, which agrees with the hypothesis that complexes 1 and 2 can be seen as model rhenium complexes of this radiopharmaceutical.Antimicrobial and DNA gyrase inhibition studies performed with complexes 2 and 3 have shown a very similar behaviour between complex 2 and the free antibiotic, whereas complex 3 exhibit a lower antimicrobial activity.Based on a joint analysis of the data reported in the literature and the chemical and biological results obtained in this study, a tentative proposal to explain some aspects of the behaviour of Tc-ciprofloxacin radiopharmaceutical has been made.     

Syntheses, crystal structures, and characterization of heteronuclear complexes based on a versatile ligand with both acetylacetonate and bis(2-pyridyl) units

A new type of multidentate ligand with both acetylacetonate and bis(2-pyridyl) units on the 1,3-dithiole moiety, 3-[2-(dipyridin-2-yl-methylene)-5-methylsulfanyl-[1,3]dithiol-4-ylsulfanyl]-pentane-2, 4-dione (L), has been prepared. Through reactions of the ligand with Re(CO)₅X (X = Cl, Br), new rhenium(I) tricarbonyl complexes ClRe(CO)₃(L) (2) and BrRe(CO)₃(L) (3), have been obtained. With the use of 2 or 3 as the precursors, the further reactions with (Tp^Ph2)Co(OAc)(Hpz^Ph2) (Tp^Ph2 = hydrotris(3,5-diphenylpyrazol-1-yl)borate); Hpz^Ph2 = 3,5-diphenyl-pyrazole) or M(OAc)₂(M = Mn, Zn), afford four new heteronuclear complexes: ClRe(CO)₃(L)Co(Tp^Ph2) (4), BrRe(CO)₃(L)Co(Tp^Ph2) (5), [ClRe(CO)₃(L)]₂Mn(CH₃OH)₂ (6) and [ClRe(CO)₃(L)]₂Zn(CH₃OH)₂ (7), respectively. Crystal structures of complexes 2 and 4-7 have been determined by X-ray diffraction. Their absorption spectra, photoluminescence and magnetic properties have been studied.